glp-1 weight loss overview with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans GLP-1 Weight Loss Drug Market

Validation delays lengthen time-to-market

Bariatric surgery changes the stomach and/or intestines to support meaningful, long-term weight loss and improve health conditions such as type 2 diabetes, sleep apnea and high blood pressure

Together, these data highlight the impact of increased food intake on transit time and SCFA production

No downtime is needed after the treatment

Highly Significant Long-term Health Benefits for All Reduction in Major Cardiac Events: Studies have shown a significant decrease in major cardiac events, including a 27% reduction in fatal heart attacks

Se deriva de la molcula de GIP sobre la que se han realizado modificaciones en la cadena peptdica que aportan capacidad de interaccin con los receptores de GIP, GLP-1 y GCG